SCHEMBL7724422

SCHEMBL7724422

O=C(Cc1ccccc1Cl)Nc1ccccc1O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.62
KCNQ2 O43526 1/20 0.60
PARP14 Q460N5 1/20 0.56
KCNJ5 P48544 3/20 0.56
KCNJ3 P48549 3/20 0.56
ERCC1 P07992 1/20 0.54
ERCC4 Q92889 1/20 0.54
KMT2A Q03164 4/20 0.51
GAA P10253 2/20 0.51
NPC1 O15118 2/20 0.51
ALDH1A1 P00352 2/20 0.51
RAB9A P51151 2/20 0.51
HPGD P15428 1/20 0.51
TSHR P16473 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
MEN1 O00255 3/20 0.51
MAPK8 P45983 1/20 0.51
LMNA P02545 1/20 0.51
TTR P02766 1/20 0.50
KCNJ6 P48051 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7736629 0.85 MEN1 (0.70) KCNQ2KCNJ5KCNJ3ERCC1ERCC4
SCHEMBL8788960 0.83 MAPT (0.55) MAPTKCNQ2PARP14KCNJ5KCNJ3
SCHEMBL28600470 0.81 KMT2A (0.66) MAPTKCNQ2KCNJ5KCNJ3KMT2A
SCHEMBL8632192 0.81 KCNQ2 (0.58) KCNQ2PARP14KCNJ5KCNJ3KMT2A
SCHEMBL8636686 0.81 MAPK8 (0.67) KCNQ2PARP14KCNJ5KCNJ3KMT2A
SCHEMBL6579874 0.79 KDM4E (0.52) MAPTKCNQ2PARP14KCNJ5KCNJ3
SCHEMBL11285417 0.78 KMT2A (0.70) MAPTKMT2AGAAALDH1A1HPGD
SCHEMBL28618234 0.78 ALDH1A1 (0.54) MAPTKCNQ2PARP14KCNJ5KCNJ3
SCHEMBL28600464 0.78 MAPK10 (0.68) KCNQ2KMT2AGAAALDH1A1TSHR
SCHEMBL28736029 0.77 TTR (0.57) KCNJ5KCNJ3ERCC1ERCC4KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6372770-B1 TREATING A MAMMAL SUFFERING FROM A DISEASE STATE SELECTED FROM THE GROUP CONSISTING OF ASTHMA, ALLERGIES, INFLAMMATION, DEPRESSION, DEMENTIA, ATOPIC DISEASES, RHINITIS AND DISEASE STATES ASSOCIATED WITH ABNORMALLY HIGH PHYSIOLOGICAL LEVELS OF EURO-CELTIQUE, S.A. 2002-04-16 US disclosed
EP-0785927-A4 NOVEL BENZOXAZOLES EURO CELTIQUE SA (LU) 1997-12-29 EP disclosed
EP-0785927-A1 NOVEL BENZOXAZOLES Euroceltique S.A. (LU) 1997-07-30 EP disclosed
WO-1996011917-A1 NOVEL BENZOXAZOLES EURO-CELTIQUE, S.A. (LU) 1996-04-25 WO disclosed